CAS 10543-57-4 - China Factory, Suppliers, Manufacturers

CAS 10543-57-4, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

N,N,N',N'-Tetraacetylethylenediamine TAED CAS 10543-57-4 Purity 90.0-94.0 (HPLC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — TAED CAS 10543-57-4 Purity 90.0~94.0% (HPLC)
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...

2022.08.08 17:43:57
2022.03.02 20:04:10
2022.02.13 03:36:44
2022.02.05 01:31:22
2022.01.25 01:46:02
2021.10.17 05:02:10

CAS 10543-57-4 - China Factory, Suppliers, Manufacturers

Related Products

TAED CAS 10543-57-4 Purity 90.0~94.0% (HPLC)

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

2,2,2-Trifluoroethyl Trifluoromethanesulfonate CAS 6226-25-1 Purity >98.0% (GC)

Ethyl 2-Bromopropionate CAS 535-11-5 Purity >99.0% (GC) Factory

Aluminum Oxide CAS 1344-28-1 99.99% Metals Basis, 6~7 μm

3-Ethylpyridine CAS 536-78-7 Purity ≥99.0% (GC) Factory

Epalrestat CAS 82159-09-9 Purity >99.5% (HPLC) Factory

2-Naphthylboronic Acid CAS 32316-92-0 Purity >99.5% (HPLC) Factory Hot Sale

Boc-Cys-OH CAS 20887-95-0 Boc-L-Cysteine Assay 98.5~100.5% (Titration)

N-thiophen-3-ylbenzamide CAS 79128-75-9 Purity >99.0% (GC) Manufacturer

Ramelteon Acrylonitrile CAS 196597-79-2 Ramelteon Intermediate Purity >98.0% (HPLC)

N-Methylaniline CAS 100-61-8 Purity >98.0% (GC)

(Ethoxymethylene)malononitrile CAS 123-06-8 Purity >98.5% (GC) Factory

Ethyl (S)-4-Chloro-3-Hydroxybutyrate CAS 86728-85-0 Assay ≥98.0% (GC) Factory High Purity

Xi presents award to top scientists

Paxlovid: what we know about Pfizer's Covid-19 pill

Yellow phosphorus and phosphoric acid rose together

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Method Of Analyzing Palladium Content In Palladium Catalysts

2022.08.08 17:43:57

2022.03.02 20:04:10

2022.02.13 03:36:44

2022.02.05 01:31:22

2022.01.25 01:46:02

2021.10.17 05:02:10

related search